(a) Identification.
         A leucine aminopeptidase test system is a device intended to measure the activity of the enzyme leucine amino-peptidase in serum, plasma, and urine. Leucine aminopeptidase measurements are used in the diagnosis and treatment of liver diseases such as viral hepatitis and obstructive jaundice.
     
    
        
        (b) Classification.
         Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of  part 807 of this chapter subject to  § 862.9.
     
    
        
            Code of Federal Regulations
        
        [52 FR 16122, May 1, 1987, as amended at 65 FR 2307, Jan. 14, 2000]